Join us for a global seminar on person-centered care using asparaginase therapies for acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL). Featuring highlights from a recent European Hematology Association (EHA) Congress presentation in Madrid, this session is designed to encourage the exchange of ideas between international thought leaders and attendees. This 30-minute, live, non-certified social media event will feature an international panel of experts who will discuss the unique role of asparaginase therapies in the treatment of ALL/LBL, the landscape of available asparaginase agents and their common toxicities, and best practices for preventing and managing adverse events to optimize patients’ quality of life and treatment experience. Throughout the event, online learners will be able to submit questions for the faculty to discuss. This event will broadcast live on Facebook, LinkedIn, Youtube, and X/Twitter on Thursday, 11 July, 2024 at 15:30 CEST/14:30 BST (European audiences) and 9:30 am EDT/8:30 am CDT (U.S. audiences). FACULTY: - Nicola Goekbuget, MD – Frankfurt, Germany - Sandra Kurtin, PhD, ANP-BC, AOCN, FAPO – Tucson, Arizona, United States - Diane C. Robinson, PhD – London, United Kingdom Supported by an independent educational grant from Jazz Pharmaceuticals, Inc. Presented through a collaboration between Medscape Global Oncology and Cancer Support Community.
Medscape
Health, Wellness & Fitness
New York, NY 125,308 followers
The leading online global destination for physicians and healthcare professionals: https://wb.md/2EPrMgZ
About us
Our Mission: To improve patient care with comprehensive clinical information and resources essential to physicians and healthcare professionals. Our Company: Medscape is the leading online global destination for physicians and healthcare professionals worldwide, offering the latest medical news and expert perspectives; essential point-of-care drug and disease information; and relevant professional education and CME. Medscape has over 30 distinct specialty sites for physicians, plus sites for nurses, pharmacists, dentists, and medical students. All content on Medscape.com and Medscape.org is available for free.
- Website
-
http://www.medscape.com
External link for Medscape
- Industry
- Health, Wellness & Fitness
- Company size
- 501-1,000 employees
- Headquarters
- New York, NY
- Type
- Privately Held
- Founded
- 1995
- Specialties
- medical news, medical reference, and continuing medical education
Locations
-
Primary
395 Hudson Street
New York, NY 10014, US
Employees at Medscape
Updates
-
🚨 ATTENTION: Enhance your proficiency with dermal fillers! Discover how to assess patients, select the best fillers, and craft individualized treatment plans. Boost your aesthetic practice today! 💉 Click here now to secure your spot: http://ms.spr.ly/6043lHFKc
-
Are You Able to Recognize and Treat Murine Typhus? ➡️http://ms.spr.ly/6047Yk3xL
-
📢 New! Updated Salary Explorer 2024 Are you earning more or less than your peers in your specialty? Our Salary Explorer helps you gain visibility into competitive physician salaries. ➡️ Access our free tool here: http://ms.spr.ly/6043lKNe3
-
In this live, 30-minute social medial event, 3 faculty experts will exchange information and opinions about where we are on the journey of protecting the fetus from congenital cytomegalovirus (CMV). Watch live as faculty discuss recent pre-pregnancy vaccination successes as well as the current understanding on the importance of vaccine timing and previous challenges with vaccine development. - - - - - Moderator: Karen Fowler, DrPH Faculty: Amanda Devereaux, RN, BSN Faculty: Sallie R. Permar, MD, PhD - - - - - Supported by an independent educational grant from Moderna, Inc.
Vaccination Success Stories: On the Road to Congenital CMV Prevention
www.linkedin.com
-
Stay at the forefront of breast cancer treatment advancements by joining this essential live discussion on the latest data from Chicago 2024. Led by top experts in breast cancer oncology, this brief and engaging 45-minute session will cover: - HER2-Directed ADCs: New findings in hormone receptor-positive HER2-low metastatic breast cancer, including chemotherapy-naive patient data. - TROP2 Targeting ADCs: In-depth discussion on this emerging treatment option. - Post-Progression Treatment: Strategies following progression on first-line CDK 4/6 inhibitors plus endocrine therapy. Bring your questions to share with our esteemed faculty panel. - - - - - Moderator: Fabrice André, MD, PhD Faculty: Aditya Bardia, MD, MPH, FASCO Faculty: Erika Hamilton, MD - - - - - Earn free 0.75 CPD. Access for credit will be shared at the end of this live event. Click the link to view the Accreditation and Disclosure details before participating: https://lnkd.in/gtnUUYFU Supported by an independent educational grant from AstraZeneca.
Ask the Expert: Understanding the Latest Advances in Breast Cancer
www.linkedin.com
-
How can molecular profiling guide cancer therapy? Join our experts to learn how to best utilize molecular testing in clinical practice. ➡️ http://ms.spr.ly/6048lKY8I
-
Review data and strategies to diagnose and treat patients with ATTR-PN accurately and early. 🌐 Developed in partnership with CMEPlanet ➡️ http://ms.spr.ly/6043lJTfU
Insights into Transthyretin Amyloid Polyneuropathy (ATTR-PN): From Basic Science to Best Patient Care
medscape.org
-
🚨 ALERT: Use code "CINCINNATI" for 30% off the Psychopharmacology Update. 📚 Immerse yourself in the newest psychiatric treatments & research. Expert faculty, groundbreaking knowledge. Transform your approach! Click here to 🔒 in the rate: http://ms.spr.ly/6046lH22G #PsychPharm24
-
Seizures not stopping? Find out what to do next when focal seizures are not adequately controlled and how to add-on and switch therapies to achieve better seizure control. ➡️ http://ms.spr.ly/6047Ygmdl
Focal Epilepsy: Expert Case Review of Inadequately Controlled Seizures
medscape.org